Cargando…

Resistance to chemotherapy

Detalles Bibliográficos
Autor principal:	Hofmann, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570504/ https://www.ncbi.nlm.nih.gov/pubmed/18781177 http://dx.doi.org/10.1038/sj.bjc.6604663

Ejemplares similares

Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma
por: Verma, Priyanka, et al.
Publicado: (2017)

m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1
por: Wang, Jiyan, et al.
Publicado: (2022)

Tackling Chemotherapy-induced Alopecia
por: Gude, Dilip
Publicado: (2012)

Combination chemotherapy for advanced colorectal cancer
por: Mason, M, et al.
Publicado: (2003)

Chemotherapy and quality of life in advanced NSCLC
por: Farrugia, D, et al.
Publicado: (2001)

Comment: Intra-arterial chemotherapy for retinoblastoma
por: Kaur, Savleen, et al.
Publicado: (2017)

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
por: Boeck, S, et al.
Publicado: (2014)

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
por: Shamash, J, et al.
Publicado: (2000)

Can a rational design for metronomic chemotherapy dosing be devised?
por: Maraveyas, A, et al.
Publicado: (2005)

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
por: Bhattacharyya, J, et al.
Publicado: (2012)

Chemotherapy-Induced or Chemotherapy-Associated? Does Physical Therapy Play a Role in Prevention and/or Management of Peripheral Neurotoxicity and Neuropathy?
por: Kumar, Senthil Paramasivam, et al.
Publicado: (2013)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
por: Gu, Fei-fei, et al.
Publicado: (2016)

Chemotherapy and quality of life in advanced NSCLC – reply
por: Anderson, Heather, et al.
Publicado: (2001)

Oral Cavity Lesions in Patients after Chemotherapy
por: Tirgar Tabari, S, et al.
Publicado: (2011)

Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Prediction of neoadjuvant chemotherapy response in breast cancer
por: Myllys, Maiju
Publicado: (2021)

The need to optimize chemotherapy regimens for chemo-immunotherapy
por: Inamura, Kentaro, et al.
Publicado: (2022)

p21 is necessary for the beneficial effects of fasting during chemotherapy
por: Plaza, Adrián, et al.
Publicado: (2022)

NRF2 activation induced by PML‐RARα promotes microRNA 125b‐1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia
por: Yu, Xibao, et al.
Publicado: (2021)

Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2021)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Is primary chemotherapy effective in large hydatid cyst of liver?
por: Gangopadhyay, A. N., et al.
Publicado: (2009)

Reply to ‘Malignant pericardial effusion: sclerotherapy or local chemotherapy?’
por: Kunitoh, H, et al.
Publicado: (2009)

Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
por: Cho, Hyungwoo, et al.
Publicado: (2016)

Palliative Chemotherapy in Elderly Patient with Comorbidities: Is It a Paradox?
por: Goyal, Sumit, et al.
Publicado: (2019)

Trastuzumab–Docetaxel Combination Chemotherapy Induced Severe Onychopathy
por: Sonthalia, Sidharth, et al.
Publicado: (2017)

Anaesthesia concerns for Peritonectomy with Hyperthermic Intraoperative Peritoneal Chemotherapy
por: Saraswat, Namita, et al.
Publicado: (2019)

Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
por: Kepka, Lucyna, et al.
Publicado: (2021)

Comment on ‘risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy’
por: Tong, Wing H, et al.
Publicado: (2023)

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Khan, O A, et al.
Publicado: (2012)

Oral Tegafur/folinic acid chemotherapy decreases phenytoin efficacy
por: Veldhorst-Janssen, N M L, et al.
Publicado: (2004)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Alliot, C, et al.
Publicado: (2004)

Why Coverage of Influenza Vaccine Is Not Enough in Patients Receiving Chemotherapy?
por: Meidani, Mohsen, et al.
Publicado: (2011)

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Dickinson, P D, et al.
Publicado: (2012)

Battling Chemotherapy-induced Nausea and Vomiting in Cancer Palliative Care
por: Gude, Dilip
Publicado: (2011)

Internet chemotherapy information is of good quality: assessment with the DISCERN tool
por: Som, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hlrp11n4mgbmkokokj1ev75lve